Insider sales are immaterial in size relative to market cap and consistent with post-earnings liquidity diversification. The CSO's exercise-and-sell pattern is mechanical (not informational). The President's $1.9M sale is notable in absolute terms but still under 0.01% of market cap. No follow-through action warranted — monitor for larger sales or an unusual increase in selling frequency.
Price Chart
Executive Summary
The CSO and President of R&D at Incyte sold a combined $2.16M in open-market shares in the week following the Q2 2026 earnings release. The CSO's sales were part of a planned exercise-and-sell pattern (option exercises paired with same-day sales), while the President's $1.9M sale was a single large open-market disposition. The total open-market sales represent ~0.009% of the $24B market cap — trivial in proportional terms. Per the academic literature, insider sales are weak predictors (especially when liquidity-driven), and the cluster CALIBRATION data shows an average net alpha of +0.53% for this filing type, with a win rate of 50% at T+20, indicating no reliable directional signal.
Key Financial Metrics
Key Facts
- President Pablo J. Cagnoni sold 15,902 shares at ~$119.70 for ~$1.90M on 2026-07-31
- CSO Patrick A. Mayes sold 2,167 shares at ~$119.47 for ~$261K on 2026-07-31
- Mayes also engaged in multiple option exercises and same-day sales on 2026-07-31 and 2026-08-03, totaling ~$4.4M in combined sales across both dates, all paired with derivative exercises — consistent with a pre-planned liquidity/vesting pattern
- Total open-market sales of ~$2.16M represent ~0.009% of Incyte's $24B market cap
- The cluster follows Incyte's Q2 2026 beat-and-raise earnings (EPS $2.81 vs $2.15 consensus, revenue $1.67B vs $1.49B), which included a one-time CMS settlement benefit
- The cluster is strongly C-suite (President of R&D and CSO) but the sales are small in proportional terms and the CSO's trades follow a mechanical exercise-and-sell pattern
Financial Impact
Total open-market sales of ~$2.16M, representing ~0.009% of Incyte's $24B market cap. Negligible proportional impact.
Risk Factors
- If additional C-suite sales emerge in the next 30 days, the cluster could signal broader insider distribution
- The Q2 beat included a $246M one-time CMS benefit — if ex-item revenue trends soften, selling could accelerate
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-INCY-1785902420714 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | Insider Cluster | $120.16 $122.19 | ▼ −1.69% | ▼ −3.68% | $115.30 (+4.04%) |
Aug 7, 2026 8w ago | Insider Cluster | $121.55 $124.40 | ▲ +2.34% | ▲ +3.26% | $115.30 (−5.14%) |
Aug 4, 2026 8w ago | Insider Cluster | $120.60 $124.50 | ▲ +3.23% | ▲ +4.47% | $115.30 (−4.39%) |
Jul 28, 2026 9w ago | 8-K | $129.93 $129.72 | ▼ −0.16% | ▼ −3.54% | $115.30 (−11.26%) |
Jul 20, 2026 10w ago | Insider Cluster | $115.65 $123.50 | ▲ +6.79% | ▲ +2.67% | $115.30 (−0.30%) |
Jul 20, 2026 10w ago | Insider Cluster | $115.65 $123.50 | ▲ +6.79% | ▲ +2.67% | $115.30 (−0.30%) |
Jun 8, 2026 16w ago | 8-K | $100.64 $115.62 | ▲ +14.88% | ▲ +13.25% | $115.30 (+14.57%) |
May 27, 2026 18w ago | DEFA14A | $97.26 $108.46 | ▲ +11.52% | ▲ +13.82% | $115.30 (+18.55%) |
Feb 28, 2026 30w ago | Institutional Cluster | $99.73 $90.31 | ▼ −9.45% | ▼ −1.51% | $115.30 (+15.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access